drugset / Trial / NCT00533364

Effect of SBG in Patients With Breast Cancer

NCT00533364 ↗

Phase 1/2 Completed 11 enrolled Biotec Pharmacon ASA
NaSingle-groupOpen-labelTreatment

Summary

This study is set up to determine whether soluble beta-glucan (SBG) has * unfavourable side effects * beneficial treatment effects when given in combination with standard antibody and chemotherapy to patients with breast cancer.

Timeline

Start
2007-01
Primary completion
2009-08
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Soluble beta-glucan Unknown — Oral

Indications